Safelist CRN—be sure you're getting the information you need

Our new format newsletter, The CRN Supplement, publishes weekly on Thursdays! 

Member feedback from our polls indicated overwhelming support for a weekly newsletter as opposed to a daily one. In response, CRN is replacing the Daily Supplement with a new once-a-week streamlined newsletter to include all the content you've come to rely on, and more. And, if you haven’t already, be sure to connect with CRN on LinkedIn and Twitter.

Access Daily Supplement archives here.

JUNE 1, 2023

More science behind the supplements / Melatonin in focus / June calendar / And more

MAY 25, 2023

Good news about multivitamins / FDA CBD stakeholder session today / Legal claims for non-lawyers / Catch up on producer packaging responsibility / And more

MAY 23, 2023

INTERIM ALERT: FDA CBD stakeholder call Thursday, May 25, at 3 pm Eastern

MAY 18, 2023

Mister emphasizes melatonin safety / Catch up on counterfeiting / Doing better by women in the workplace as well as in nutrition policy

MAY 11, 2023

FDA Drug Preclusion Clause interpretation threatens innovation, consumer choice / Day on the Hill back in person June 21 / Melatonin Task Force reconvenes / And more

MAY 10, 2023

INTERIM ALERT: Citizen Petition calls on FDA to reconsider Drug Preclusion Clause interpretation

MAY 4, 2023

Mister talks 2023 policy priorities—drug preclusion and more / Complementary educational opportunities for CRN members / Be part of CRN history

APRIL 27, 2023

JAMA Research Letter on melatonin gummies / CRN monitoring state packaging, age restriction legislation / BSCG reports from Partnership for Clean Competition Conference — and more

APRIL 25, 2023

INTERIM ALERT: JAMA Research Letter raises false alarm over levels of melatonin in gummies

APRIL 24, 2023

INTERIM ALERT: Embargoed—Melatonin gummies topic of JAMA Research Letter

APRIL 20, 2023

FTC penalty offense notices / Supporting Codex sustainability efforts / FSA and HSA holders want supplements covered / And more

APRIL 13, 2023

Supplements and pregnancy / WellComms to offer streaming virtual option / Case by case enforcement discretion won’t solve drug preclusion issues – And more

APRIL 6, 2023

Reaching influential RDs with science-based info on supplements / CRN committee meetings & Toxicology Workshop next week / And more

MARCH 30, 2023

FDA must prioritize supplements / CRN and members in the news / And more

MARCH 23, 2023

Engaging on sustainability solutions / Protecting supplement access in the states / And more

MARCH 16, 2023

What’s next for CBD? / State age-restriction proposals persist—CRN in Maryland today / And more

MARCH 9, 2023

Elevating supplements as essential to public health / Report from ExpoWest, Codex, and more